Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma

…, CJ Marsit, HH Nelson, AE Birnbaum… - … , biomarkers & prevention, 2013 - AACR
Background: Gastric reflux can reach into the upper airway, inducing cellular damage in the
epithelial lining. This condition is believed to be a risk factor for development of …

Pneumonectomy after neoadjuvant chemotherapy and radiation for advanced-stage lung cancer

T Ng, AE Birnbaum, JP Fontaine, D Berz… - Annals of surgical …, 2010 - Springer
Background Intergroup 0139 Trial suggests an increase in mortality after pneumonectomy
in patients receiving preoperative chemotherapy and radiation. We evaluate our outcomes …

[HTML][HTML] Pathologic response after neoadjuvant carboplatin and weekly paclitaxel for early-stage lung cancer: a Brown University oncology group phase II study

S Ahmed, AE Birnbaum, HP Safran, TA Dipetrillo… - Journal of Thoracic …, 2011 - Elsevier
Introduction Pathologic complete response (pCR) to neoadjuvant chemotherapy is associated
with improved survival in solid tumors. Southwest Oncology Group 9900 demonstrated a 9…

Abstract CT164: Tisotumab vedotin (TV) in squamous cell carcinoma of head and neck (SCCHN): interim analysis from innovaTV 207

B Cirauqui, S Salas, W William, AE Birnbaum… - Cancer Research, 2023 - AACR
… 2 pts discontinued treatment due to an AE (PSN and dry eye, n=1 each). 11 pts received 3
Birnbaum, Kristi Schmidt, Xuesong Guan, Ibrahima Soumaoro, Leonardo Nicacio, Fortunato …

[PDF][PDF] Solitary pulmonary nodule: pleuropulmonary synovial sarcoma

RC Ward, AE Birnbaum, BI Aswad… - Rhode Island Medical …, 2014 - rimed.org
Pleuropulmonary synovial sarcoma (PPSS) is an extremely rare primary malignancy of the
lung. We present a case of a middle-aged female with PPSS that was initially discovered as …

Induction cetuximab (C) followed by C, paclitaxel (P), carboplatin (CP) and concurrent radiation (RT) for locoregionally advanced squamous cell carcinoma of the …

AE Birnbaum, TT Johnson, R Rathore… - Journal of Clinical …, 2007 - ascopubs.org
16504 Background: C is an IgG1 chimerized, monoclonal antibody that binds specifically to
the epidermal growth factor receptor, which is expressed in 90–100% of HNC. We conducted …

innovaTV 207: New combination dosing cohorts in the open label phase 2 study of tisotumab vedotin in solid tumors.

X Le, BA Carneiro, DS Hong, AE Birnbaum, MH Taylor… - 2022 - ascopubs.org
TPS6100 Background: Tisotumab vedotin (TV; TIVDAK) is a tissue factor (TF)-directed
antibody-drug conjugate that has been granted accelerated approval in the US for treatment of …

Radium-223 following front-line chemotherapy for patients with non-small cell lung cancer and bone metastases.

AM Taber, D Riley, AJ Olszewski, AE Birnbaum… - 2018 - ascopubs.org
e21211 Background: Radium-223 dichloride (Ra-223) is a targeted- alpha particle emitting
therapy directed at bone metastases with high-linear energy transfer at a short-range. This …

Phase I study of ridaforolimus with cetuximab for patients with advanced non-small cell lung cancer (NSCLC), colorectal cancer, and head and neck cancer.

AM Taber, H Khurshid, K Perez, AE Birnbaum… - 2013 - ascopubs.org
8075 Background: mTOR inhibition may overcome PI3K/AKT pathway mediated resistance
to anti-EGFR therapy. We performed a phase I study to determine the dose-limiting toxicity (…

'I Can't Eat, Speak, or Kiss My Wife. It's Half a Life, but at Least I'm Still Alive.'Navigating the Sequelae of Head and Neck Cancer (TH307)

DL Guyer, S Misra, AE Birnbaum, J Jones… - Journal of Pain and …, 2020 - jpsmjournal.com
`I Can't Eat, Speak, or Kiss My Wife. It's Half a Life, but at Least I'm Still Alive.' Navigating the
Sequelae o Page 1 Describe the extent to which nephrologist/dialysis center medical director …